基础医学与临床 ›› 2008, Vol. 28 ›› Issue (6): 614-617.

• 研究论文 • 上一篇    下一篇

shRNA抑制人肺癌细胞A549 SURVIVIN基因表达

王润秀 谢富华 汤显湖 吴斌 梁念慈   

  1. 赣南医学院 赣南医学院 赣南医学院 广东医学院 广东医学院附属医院
  • 收稿日期:2007-08-01 修回日期:2007-10-30 出版日期:2008-06-25 发布日期:2008-06-25
  • 通讯作者: 王润秀

ShRNA inhibited SURVIVIN expression in human lung cancer cell A549

Run-xiu WANG, Fu-hua XIE, Xian-hu THANG, Bin WU, Nian-ci LIANG   

  • Received:2007-08-01 Revised:2007-10-30 Online:2008-06-25 Published:2008-06-25
  • Contact: Run-xiu WANG,

摘要: 目的 构建存活素(SURVIVIN)基因的短发夹RNA (shRNA)表达质粒,为肺癌RNA干扰(RNAi)途径的基因治疗打下基础。方法 设计并合成SURVIVIN短发夹结构模板序列,与穿梭载体重组质粒后转染人肺癌细胞A549,通过RT-PCR法筛选出抑制效果最强的质粒;MTT和Western blot法检测该质粒对细胞增殖和SURVIVIN表达的影响。结果 构建和筛选出抑制作用最强的质粒;该质粒能明显抑制A549细胞的增殖和SURVIVIN的表达。结论 在RNAi 的介导下,SURVIVIN的表达被下调,为肺癌的基因治疗提供理论依据。

Abstract: To construct expression vector with short hairpin RNA of survivin,which paves the way for lung cancer RNAi-mediated therapy. Methods Eight strands of DNA fragement with the structure of survivin shRNA were designed and synthesized.After annealed,the double Objective To construct shRNA expression vector of SURVIVIN for RNAi-mediated therapy on lung cancer. Methods DNA templates of SURVIVIN shRNA were designed,synthesized and cloned into the shuttle vector to get recombinant plasmids. After plasmids were transfected into A549 cells, the one with the most repression was screened by means of RT-PCR. Then MTT and Western blot were done to ascertain whether the proliferation of A549 cells were inhibited and SURVIVIN was down-regulated.Results The recombinants were constructed and screened successfully. The proliferation of A549 cells and SURVIVIN expression were repressed. Conclusion Mediated by RNAi, SURVIVIN expression was down-regulated,which theoretically based on gene therapy on huaman lung cancer.